Screener
Olema Pharmaceuticals, Inc. OLMA Free cash flow
Discontinued — last reported Q3 '25
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Olema Pharmaceuticals, Inc.’s reported figures.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed November 10, 2025. Open the filing →
- Filed
- Nov 10, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-273236
FAQ
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- Olema Pharmaceuticals, Inc. (OLMA) reported free cash flow of -$34.53M in Q3 2025.
- How has Olema Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Olema Pharmaceuticals, Inc.'s free cash flow decreased by 27.8% year-over-year, from -$27.02M to -$34.53M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s free cash flow?
- Over 2 years (2021 to 2024), Olema Pharmaceuticals, Inc.'s free cash flow has grown at a 41.4% compound annual growth rate (CAGR), from -$52.27M to -$104.51M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Olema Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude